The FDA has approved zolbetuximab-clzb (VYLOY) as a first-line targeted therapy, in combination with chemotherapy, for the ...

Sanofi and Orano Med have partnered to accelerate the development of next-generation radioligand therapies for rare cancers, ...

Developed by AI, Lantern Pharma's investigational drug LP-184 has received FDA Fast-Track Designation for glioblastoma.

The FDA has approved Genentech’s Itovebi™ (inavolisib) as a targeted therapy for adults with advanced hormone ...

The Merlin test (CP-GEP), a molecular diagnostic tool developed by SkylineDx, significantly reduces the need for sentinel ...

Bayer and MOMA Therapeutics have announced a new collaboration aimed at advancing precision cancer treatments. The ...

ADCs are at the forefront of cancer treatment, providing targeted therapies with promising results for lung cancer. We have ...

Antibody-drug conjugates (ADCs) represent a significant breakthrough in oncology, offering targeted treatments, for lung ...